Summary
Hereditary coproporphyria (HCP) is the least common of the three autosomal dominant acute porphyrias. To compare the sensitivity of metabolite measurements for the identification of asymptomatic HCP, we carried out a molecular and biochemical investigation of a large family in which HCP is caused by a previously unreported frameshift mutation (c.119delA). Thirteen of 19 asymptomatic family members, aged 10–72 years, were shown by mutational analysis to have HCP. The faecal coproporphyrin isomer III:I ratio was increased in all of these 13 family members; faecal total porphyrin concentration and urinary porphyrin excretion were increased in 11 and 8 of them, respectively. Plasma porphyrin concentrations were marginally increased in three individuals and plasma fluorescence emission scanning showed a porphyrin peak at 618 nm in two of these. Our results add to the evidence that an increased faecal porphyrin coproporphyrin III:I ratio is a highly sensitive test for the detection of clinically latent HCP in individuals over the age of 10 years; its sensitivity below this age remains uncertain. They also show that plasma fluorescence emission scanning is not useful for the investigation of families with HCP.
Similar content being viewed by others
References
Blake D, McManus J, Cronin V, Ratnaike S (1992) Faecal coproporphyrin isomers in hereditary coproporphyria. Clin Chem 38: 96–100.
Brodie MJ, Thompson GG, Moore MR, Beattie D, Goldberg A (1977) Hereditary coproporphyria: demonstration of the abnormalities of haem synthesis in peripheral blood. Q J Med 46: 229–241.
Deacon AC, Elder GH (2001) Front line tests for the investigation of suspected porphyria. J Clin Pathol 54: 500–507.
Gross U, Puy H, Meissauer U (2002) A molecular, enzymatic and clinical study in a family with hereditary coproporphyria. J Inherit Metab Dis 25: 279–286.
Hift RJ, Davidson BP, van der Hooft C, Meissner DM, Meissner P (2004) Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity using detection of protoporphyrinogen oxidase mutations as a standard. Clin Chem 50: 915–923.
Hindmarsh JT, Oliveras L, Greenway DC (1999) Plasma porphyrins in the porphyrias. Clin Chem 45: 1070–1076.
Jacob J, Doss M (1995) Excretion pattern of faecal coproporphyrin isomers I–IV in human porphyrias. Eur J Clin Chem Clin Biochem 33: 893–901.
Kaplowitz N, Javitt N, Kappas A (1972) Coproporphyrin I and III excretion in bile and urine. J Clin Invest 51: 2895–2899.
Kauppinen R, von und ze Fraunberg M (2002) Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem 48: 1891–1900.
Kühnel A, Groß U, Doss MO (2000) Hereditary coproporphyria in Germany: clinical–biochemical studies in 53 patients. Clin Biochem 33: 465–473.
Lamoril J, Puy H, Whatley SD, et al (2001) Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype–phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria. Am J Hum Genet 68: 1130–1138.
Lim CK, Peters TJ (1984) Urine and faecal porphyrin profiles by reversed-phase high-performance chromatography in the porphyrias. Clin Chim Acta 139: 55–63.
Lockwood WH, Poulos V, Rossi E, Curnow DH (1985) Rapid procedure for fecal porphyrin assay. Clin Chem 31: 1163–1167.
Longas MO, Poh-Fitzpatrick M (1982) A tightly bound protein–porphyrin complex isolated from the plasma of a patient with variegate porphyria. Clin Chim Acta 118: 219–228.
Martasek P (1998) Hereditary coproporphyria. Semin Liver Dis 18: 25–32.
Poh-Fitzpatrick A (1980) Plasma poprhyrin fluorescence marker for variegate porphyria. Arch Dermatol 116: 543–547.
Poh-Fitzpatrick MB, Sosin AE, Bemis J (1982) Porphyrin levels in plasma and erythrocytes of chronic hemodialysis patients. Am Acad Dermatol 7: 100–104.
Susa S, Daimon M, Ono H, Li S, Yoshida T, Kato T (2003) The long, but not the short, presequence of human coproporphyrinogen oxidase is essential for its import and sorting to mitochondria. Tohoku J Exp Med 200: 39–45.
Westerlund J, Pudek M, Schreiber WE (1998) A rapid and accurate spectrofluorimetric method for quantification and screening of urinary porphyrins. Clin Chem 34: 345–351.
Whatley SD, Puy H, Morgan RR, et al (1999) Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. Am J Hum Genet 65: 984–994.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allen, K.R., Whatley, S.D., Degg, T.J. et al. Hereditary coproporphyria: Comparison of molecular and biochemical investigations in a large family. J Inherit Metab Dis 28, 779–785 (2005). https://doi.org/10.1007/s10545-005-0092-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-0092-z